成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Anti-phospho-AKT1 + AKT2 + AKT3antibody -磷酸化蛋白激酶B抗體,phospho-AKT1 + AKT2 + AKT3 (Thr308+Thr309+Thr305)
  • Anti-phospho-AKT1 + AKT2 + AKT3antibody -磷酸化蛋白激酶B抗體,phospho-AKT1 + AKT2 + AKT3 (Thr308+Thr309+Thr305)
  • Anti-phospho-AKT1 + AKT2 + AKT3antibody -磷酸化蛋白激酶B抗體,phospho-AKT1 + AKT2 + AKT3 (Thr308+Thr309+Thr305)

Anti-phospho-AKT1 + AKT2 + AKT3antibody -磷酸化蛋白激酶B抗體

價格 1280 1980 2900
包裝 50ul 100ul 200ul
最小起訂量 50ul
發(fā)貨地 上海
文件下載 檢測報(bào)告COA
更新日期 2024-12-30
QQ交談 微信洽談

產(chǎn)品詳情

中文名稱:Anti-phospho-AKT1 + AKT2 + AKT3antibody -磷酸化蛋白激酶B抗體英文名稱:phospho-AKT1 + AKT2 + AKT3 (Thr308+Thr309+Thr305)
品牌: 滬震生物產(chǎn)地: 中國/上海
保存條件: -20°C純度規(guī)格: > 99%
產(chǎn)品類別: 抗體 一抗
抗體名: AKT1 (phospho T308); AKT2 (phospho T309); AKT3 (phospho T305); p-AKT1 (phospho T308); p-AKT2 (phospho T309); p-AKT3 (phospho T305); AKT 1; AKT; AKT1; AKT-1; AKT1_HUMAN; AKT 2; AKT2; AKT-2; AKT2_HUMAN; AKT 3; AKT3; AKT-3; AKT3_HUMAN; C AKT; cAKT; MGC9965; MGC99656; Oncogene AKT1; PKB; PKB alpha; PKB-ALPHA; PKB beta; PKB gamma; PRKBA; Protein Kinase B Alpha; Protein kinase B; Proto-oncogene c-Akt; RAC Alpha; RAC alpha serine/threonine protein kinase; RAC; RAC PK Alpha; Rac protein kinase alpha; RAC Serine/Threonine Protein Kinase; RAC-alpha serine/threonine-protein kinase; RAC-PK-alpha; v akt murine thymoma viral oncogene homolog 1; vAKT Murine Thymoma Viral Oncogene Homolog 1. 靶點(diǎn): 詳見說明書
宿主: Rabbit適應(yīng)物種: 詳見說明書
克隆性: 詳見說明書濃度: 1mg/ml
應(yīng)用范圍: WB=1:500-2000 ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1μg/Test ICC=1:100 IF=1:100-500 (石蠟切片需做抗原修復(fù)) not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user.標(biāo)識物: 詳見說明書
形態(tài): 液體亞型: IgG1
免疫原: 詳見說明書貨號: HZ-R5182
用途范圍: 科研使用規(guī)格: 50ul/100ul/200ul
是否進(jìn)口: 是否單克隆: 詳見說明書
保質(zhì)期: 12個月抗原來源: 詳見說明書
標(biāo)記物: 詳見說明書產(chǎn)品用途: WB=1:500-2000 ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1μg/Test ICC=1:100 IF=1:100-500 (石蠟切片需做抗原修復(fù)) not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user.
2024-12-30 Anti-phospho-AKT1 + AKT2 + AKT3antibody -磷酸化蛋白激酶B抗體 phospho-AKT1 + AKT2 + AKT3 (Thr308+Thr309+Thr305) 50ul/1280RMB;100ul/1980RMB;200ul/2900RMB 1280 滬震生物 中國/上海 -20°C > 99% 抗體 一抗

Host:Rabbit

Target Protein:phospho-AKT1 + AKT2 + AKT3 (Thr308+Thr309+Thr305)

IR:Immunogen Range:MK(p-T)FC

Clonality:Polyclonal

Isotype:IgG

Entrez Gene:207

Swiss Prot:P31749

Source:KLH conjugated Synthesised phosphopeptide derived from human AKT1 around the phosphorylation site of Thr308:MK(p-T)FC 

Purification:affinity purified by Protein A

Storage:0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.

Background:AKT, also known as protein kinase B (PKB), is a 57 kDa serine/threonine protein kinase. There are three mammalian isoforms of Akt: AKT1 (PKB alpha), AKT2 (PKB beta) and AKT3 (PKB gamma) with AKT2 and AKT3 being approximately 82% identical with the AKT1 isoform. Each isoform has a pleckstrin homology (PH)domain, a kinase domain and a carboxy terminal regulatory domain. AKT was originally cloned from the retrovirus AKT8, and is a key regulator of many signal transduction pathways. Its tight control over cell proliferation and cell viability are manifold; overexpression or inappropriate activation of AKT has been seen in many types of cancer. AKT mediates many of the downstream events of phosphatidylinositol 3 kinase (a lipid kinase activated by growth factors, cytokines and insulin). PI3 kinase recruits AKT to the membrane, where it is activated by PDK1 phosphorylation. Once phosphorylated, AKT dissociates from the membrane and phosphorylates targets in the cytoplasm and the cell nucleus.

Size:50ul

Concentration:1mg/ml

Applications:WB(1:500-2000)
ELISA(1:5000-10000)
IHC-P(1:100-500)
IHC-F(1:100-500)
Flow-Cyt(1μg/Test)
ICC(1:100)
IF(1:100-500)

Cross Reactive Species:Human
Mouse
Rat
Chicken
Dog
Pig
Cow
Rabbit
Sheep

搜狗截圖23年04月26日1555_183.png


本產(chǎn)品僅供科研使用。不能用于人和動物治療等其它臨床診斷使用!



























































關(guān)鍵字: AKT1;AKT;AKT 1;AKT2;AKT 2;

公司簡介

上海滬震實(shí)業(yè)有限公司是一家集研發(fā)、生產(chǎn)和銷售于一體的生命科學(xué)實(shí)驗(yàn)室產(chǎn)品生物科技企業(yè)。主營產(chǎn)品:試劑盒,ELISA試劑盒,抗體,重組蛋白,血清,胎牛血清,細(xì)胞,原代細(xì)胞 細(xì)胞培養(yǎng)試劑,常用生化試劑。
成立日期 2014-05-08 (11年) 注冊資本 100萬元整
員工人數(shù) 10-50人 年?duì)I業(yè)額 ¥ 100萬以內(nèi)
主營行業(yè) 生化試劑,細(xì)胞培養(yǎng),蛋白組學(xué),分子生物學(xué),細(xì)胞生物學(xué) 經(jīng)營模式 工廠,試劑,定制,服務(wù)
  • 上海滬震實(shí)業(yè)有限公司
VIP 3年
  • 公司成立:11年
  • 注冊資本:100萬元整
  • 企業(yè)類型:有限責(zé)任公司(國內(nèi)合資)
  • 主營產(chǎn)品:ELISA試劑盒,抗體,細(xì)胞系,原代細(xì)胞,細(xì)胞培養(yǎng)試劑,重組蛋白
  • 公司地址:松江區(qū)
詢盤

Anti-phospho-AKT1 + AKT2 + AKT3antibody -磷酸化蛋白激酶B抗體相關(guān)廠家報(bào)價

產(chǎn)品名稱 價格   公司名稱 報(bào)價日期
¥1600.00
VIP9年
北京索萊寶科技有限公司
2024-12-27
詢價
VIP4年
上海冠導(dǎo)生物工程有限公司
2024-12-30
詢價
上海炎熙生物科技有限公司
2024-12-25
詢價
上海博湖生物科技有限公司
2022-09-02
內(nèi)容聲明:
以上所展示的信息由商家自行提供,內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布商家負(fù)責(zé)。 商家發(fā)布價格指該商品的參考價格,并非原價,該價格可能隨著市場變化,或是由于您購買數(shù)量不同或所選規(guī)格不同而發(fā)生變化。最終成交價格,請咨詢商家,以實(shí)際成交價格為準(zhǔn)。請意識到互聯(lián)網(wǎng)交易中的風(fēng)險是客觀存在的